Skip to main content

Table 2 Comparison of androgen levels between NYU study and CHR control group

From: Is there an androgen level threshold for aneuploidy risk in infertile women?

  NYU-Baseline CHR –Baseline CHR post DHEA
(mean & 95% CI) (mean & 95% CI) (mean & 95% CI)
DHEA (ng/dL) 290.97 261.27 to 324.031 294.733 257.46 to 337.40 595.21 539.28 to 651.141
Androstenedion (ng/dL) 60.08 55.86 to 64.622 78.98 70.56 to 88.472 123.64 110.77 to 138.002
Testosterone (ng/dL) 16.67 15.35 to 18.112 21.77 19.60 to 24.182 32.14 28.62 to 36.092
  1. 1P < 0.0001; 2P < 0.001; The table demonstrates that DHEA levels were similar between NYU and CHR patients at treatment start but post-DHEA supplementation CHR levels were significantly higher. Androstenedion and testosterone levels were even at baseline lower in NYU than CHR patients.